Christopher R. Frei is an Associate Professor of Pharmacy at The University of Texas at Austin and an Adjoint Faculty Member in the School of Medicine at The University of Texas Health Science Center at San Antonio. Dr. Frei completed his Doctor of Pharmacy degree (2001), Master's degree (2003), residency (2003), and post-doctoral training (2005) at the UT Austin and the UT Health Science Center. He joined the faculty at both universities in January 2006.
Dr. Frei is a Board Certified Pharmacotherapy Specialist who studies clinically important infectious diseases, including pneumonia, skin and soft tissue infections, and HIV. He is particularly interested in emerging antibiotic resistance among Gram-positive bacteria including Staphylococcus aureus. His research approach involves pharmacoepidemiology, comparative-effectiveness, and microbial genomics. Dr. Frei has been a principal investigator/co-investigator for 15 different studies supported by NIH, the Society of Infectious Diseases Pharmacists, and the pharmaceutical industry. He has published 70 peer-reviewed papers in leading medical and scientific journals, including JAMA Internal Medicine, the American Journal of Medicine, Antimicrobial Agents in Chemotherapy, Chest, Clinical Microbiology and Infection, Drugs, Pharmacotherapy, Journal of Antimicrobial Chemotherapy, and the Journal of the American Board of Family Medicine. He has also given more than 260 national, state, and local presentations.
In 2011, Dr. Frei was recognized as "Mentor of the Year" by the Texas Society of Health System Pharmacists, "Young Investigator of the Year" by the Society of Infectious Diseases Pharmacists, and "Distinguished Young Alumnus of the Year" by the UT Austin College of Pharmacy. He was promoted to Associate Professor with Tenure at the UT Austin in 2012.
Education & Research Ctr.
College of Pharmacy
The University of Texas
Health Science Center
7703 Floyd Curl Drive - MC 6220
San Antonio, TX
Email Address: pharmacy
Dr. Kelly Reveles, assistant professor of pharmacotherapy, is primary author of a study which found that the incidence of Clostridium difficile infection (CDI), a highly contagious gastrointestinal disease often linked to the overprescribing of antibiotics, nearly doubled between 2001 and 2010. It also determined there were no improvements in patient health outcomes, including mortality or hospital length of stay, over the study period.